• 患者服务: 与癌共舞小助手
  • 微信号: yagw_help22

QQ登录

只需一步,快速开始

开启左侧

非小细胞肺癌脑转治疗方法荟萃(更新于2011年11月9日)

    [复制链接]
1097234 492 老马 发表于 2011-10-15 20:30:11 |
累计签到:1 天
连续签到:1 天
[LV.1]初来乍到
beleon  高中二年级 发表于 2013-12-21 10:44:05 | 显示全部楼层 来自: 广东深圳
老马老师您好,
爸爸四期低分化腺癌脑转靶向请教
http://www.yuaigongwu.com/forum. ... 8&fromuid=30155
(出处: 与癌共舞)
服易3个月后,一切指标正常,CEA:4.63;
空窗20天,CEA维持在4.60;
空窗43天CEA上升到5.94;检测医院参考值范围:0-6.5;
是等CEA指标超过6.5再重新服易好,还是现在就该服易?
老马  博士一年级 发表于 2014-1-3 11:47:26 | 显示全部楼层 来自: 浙江温州
Associations between Single Nucleotide Polymorphisms in the PI3K/PTEN/AKT/mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non-Small-Cell Lung Cancer
http://clincancerres.aacrjournal ... stract.html?papetoc
Purpose:Non-small cell lung cancer (NSCLC) metastasizes fairly often to the brain, but identifying which patients will develop brain metastases (BM) is problematic. The phosphatidylinositol-3 kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) signaling pathway is important in the control of cell growth, tumorigenesis, and cell invasion. We hypothesized that genotype variants in this pathway could predict BM in patients with NSCLC. Experimental Design:We genotyped 16 single nucleotide polymorphisms (SNPs) in 5 core genes (PIK3CA, PTEN, AKT1, AKT2, and FRAP1) by using DNA from blood samples of 317 patients with NSCLC and evaluated potential associations with the subsequent development of BM, the cumulative incidence of which was estimated with Kaplan-Meier analysis. Multivariate Cox regression analysis was used to analyze correlations between genotype variants and the occurrence of BM. Results:In analysis of individual SNPs, the GT/GG genotype of AKT1: rs2498804, CT/TT genotype of AKT1: rs2494732 and AG/AA genotype of PIK3CA: rs2699887 were associated with higher risk of BM at 24 months' follow-up (respective hazard ratios [HRs] 1.860, 95% confidence interval [CI] 1.199-2.885, P=0.006; HR 1.902, 95% CI 1.259-2.875, P = 0.002; and HR 1.933, 95% CI 1.168-3.200, P=0.010). We further found that these SNPs had a cumulative effect on BM risk, with that risk being highest for patients carrying both of these unfavorable genotypes (P=0.003). Conclusions:Confirmation of our findings, the first to indicate that genetic variations in PI3K-AKT-mTOR can predict BM, in prospective studies would facilitate stratification of patients for BM prevention trials.
个人公众号:treeofhope
老马  博士一年级 发表于 2014-1-8 18:40:25 | 显示全部楼层 来自: 浙江温州
埃克替尼治疗非小细胞肺癌脑转移的回顾性研究.pdf (953.49 KB, 下载次数: 283)
老马  博士一年级 发表于 2014-1-8 18:45:29 | 显示全部楼层 来自: 浙江温州
EGFR-TKI and lung adenocarcinoma with CNS relapse.pdf (341.21 KB, 下载次数: 80)
老马  博士一年级 发表于 2014-1-8 19:25:55 | 显示全部楼层 来自: 浙江温州
Kim, J.E.; Lee, D.H.; Choi, Y.; Yoon, D.H.; Kim, S.W.; Suh, C.; Lee, J.S. Epidermal growth
receptor tyrosine kinase inhibitors as a first-line therapy for non-smokers with adenocarcinoma
of the lung having asymptomatic synchronous brain metastases. Lung Cancer 2009, 65, 351–354.

Heon, S.; Yeap, B.Y.; Britt, G.J.; Costa, D.B.; Rabin, M.S.; Jackman, D.M.; Johnson, B.E.
Development of central nervous system metastases in patients with advanced non-small cell lung
cancer and somatic EGFR mutations treated with gefinitib or erlotinib. Clin. Cancer Res. 2010,
16, 5873–82.
个人公众号:treeofhope
豆沙包呀  初中二年级 发表于 2014-1-12 15:19:11 | 显示全部楼层 来自: 江苏南通
椰子112 发表于 2011-10-15 21:29
我妈妈脑膜转移,当时吴一龙让全脑放疗。。。说有效率20~30% 所以我们没放。。。
回来以后停了10天靶向药 ...

麻烦问一下吴一龙的号怎么能挂上?直接挂专家号吗
qqabc  小学二年级 发表于 2014-1-14 20:28:29 | 显示全部楼层 来自: 江苏南京
老马 发表于 2014-1-8 19:25
Kim, J.E.; Lee, D.H.; Choi, Y.; Yoon, D.H.; Kim, S.W.; Suh, C.; Lee, J.S. Epidermal growth
recepto ...

找不到下载啊
linruyicn  小学六年级 发表于 2014-1-17 15:01:45 | 显示全部楼层 来自: 北京
谢谢,收集资料,
阿Q  大学二年级 发表于 2014-2-13 09:29:44 | 显示全部楼层 来自: 中国
老马 发表于 2013-12-13 12:14
罗氏的Brain Shuttle技术
http://www.roche.com/research_and_development/what_we_are_working_on/resear ...

罗氏的Brain Shuttle technology,能有效地将研究性抗体通过血脑屏障(BBB)转移进入大脑。
 
这个还只是临床前模型,到二三期临床不知道需要几年呢……
huanzi  大学二年级 发表于 2014-2-13 15:00:11 | 显示全部楼层 来自: 中国
本帖最后由 huanzi 于 2014-2-13 15:04 编辑

老马老师!你好!脑转信息又从头看到尾,,除了易,特入脑,还有埃克替尼,我是19突变,对易,特,埃克替尼是有效的,易,用10个月,脑转后用特8个月,现4002,收效一般,准备下月换药,2992一个月无效,299804是否试试,易特都用了换埃克替尼有用吗?看到前面的病友联合替莫唑胺,我想试试,请指导,一直无放疗,多发脑转,大部分得到好转,也发现新病灶,不知是否还可以继续药物控制,望病友们给予自身体会,在这里多谢了!
      
马太福音9:29照着你们的信给你们成全了吧。!

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

  • 回复
  • 转播
  • 评分
  • 分享
帮助中心
网友中心
购买须知
支付方式
服务支持
资源下载
售后服务
定制流程
关于我们
关于我们
友情链接
联系我们
关注我们
官方微博
官方空间
微信公号
快速回复 返回顶部 返回列表